SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension

Clinical trial NCT06804161 · RECRUITING

Trial details

NCT number: NCT06804161
Sponsor: Prof. Dr. med. Ingo Eitel
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Hypertension

Start date: 2025-12-10
Primary completion: 2032-05-30
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.